Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The interaction of Synapsin 2a and Synaptogyrin-3 regulates fear extinction in mice
Xi-Ya Shen, … , Ling-Qiang Zhu, Dan Liu
Xi-Ya Shen, … , Ling-Qiang Zhu, Dan Liu
Published January 4, 2024
Citation Information: J Clin Invest. 2024;134(4):e172802. https://doi.org/10.1172/JCI172802.
View: Text | PDF
Research Article Neuroscience

The interaction of Synapsin 2a and Synaptogyrin-3 regulates fear extinction in mice

  • Text
  • PDF
Abstract

The mechanisms behind a lack of efficient fear extinction in some individuals are unclear. Here, by employing a principal components analysis–based approach, we differentiated the mice into extinction-resistant and susceptible groups. We determined that elevated synapsin 2a (Syn2a) in the infralimbic cortex (IL) to basolateral amygdala (BLA) circuit disrupted presynaptic orchestration, leading to an excitatory/inhibitory imbalance in the BLA region and causing extinction resistance. Overexpression or silencing of Syn2a levels in IL neurons replicated or alleviated behavioral, electrophysiological, and biochemical phenotypes in resistant mice. We further identified that the proline-rich domain H in the C-terminus of Syn2a was indispensable for the interaction with synaptogyrin-3 (Syngr3) and demonstrated that disrupting this interaction restored extinction impairments. Molecular docking revealed that ritonavir, an FDA-approved HIV drug, could disrupt Syn2a-Syngr3 binding and rescue fear extinction behavior in Syn2a-elevated mice. In summary, the aberrant elevation of Syn2a expression and its interaction with Syngr3 at the presynaptic site were crucial in fear extinction resistance, suggesting a potential therapeutic avenue for related disorders.

Authors

Xi-Ya Shen, Juan Zhang, He-Zhou Huang, Shao-Dan Li, Ling Zhou, Shi-Ping Wu, Cheng Tang, Xian Huang, Zhi-Qiang Liu, Zi-Yuan Guo, Xiang Li, Heng-Ye Man, You-Ming Lu, Ling-Qiang Zhu, Dan Liu

×

Figure 6

Syn2a interacts with AA91-99 of Syngr3 via domain H.

Options: View larger image (or click on image) Download as PowerPoint
Syn2a interacts with AA91-99 of Syngr3 via domain H.
(A) Co-IP of Syn2a ...
(A) Co-IP of Syn2a and Syngr3 from the presynaptic fraction of amygdala homogenates of naive mice (n = 3 replicates). IP, immunoprecipitation; IB, immunoblotting. (B) Co-IP and quantitative analysis to evaluate the binding of Syn2a and Syngr3 from EXT-S and EXT-R mouse mPFC lysates (n = 3 replicates). (C) H293T cells were transiently transfected with the EGFP-Syn2a, EGFP-Syn2a-ΔH, EGFP-Syn2a-ΔE, and full-length Syngr3 [Syngr3(fl)-HA] plasmids. The cell lysates were collected and immunoprecipitated with an anti-HA antibody. Western blotting was performed using anti-HA and anti-EGFP antibodies. (D) H293T cell were transiently transfected with the Syngr3 (fl)-HA, Syngr3 (1-148)-HA, Syngr3 (149-229)-HA, Syngr3 (1-90)-HA or Syngr3 (91-148)-HA, and EGFP-domain H plasmids. The cell lysates were collected and immunoprecipitated with an anti-HA antibody. Western blot was performed by using anti-HA and anti-EGFP antibodies. (E) H293T cells were transiently transfected with the Syngr3 (fl)-HA, Syngr3 (deletion 91-148)-HA, Syngr3 (deletion 91–99)-HA, Syngr3 (deletion 133–148)-HA, and EGFP-domain H plasmids. The cell lysates were collected and immunoprecipitated with an anti-EGFP antibody. Western blot was performed by using anti-HA and anti-EGFP antibodies. (F) Quantitative analysis of Co-IP using the anti-EGFP antibody (n = 3 replicates). Statistical analyses among multiple groups were conducted using 1-way ANOVA followed by Bonferroni post hoc tests (F), whereas an unpaired 2-tailed t test was conducted for comparing 2 groups (B). ***P < 0.001. Values are presented as mean ± SEM.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts